Actinium Pharmaceuticals, Inc.
ATNM- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001388320
No open-market purchases or sales by Actinium Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $5.18M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Actinium Pharmaceuticals, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 54 | 1 | 47 | −6 |
| Shares | 5.30M | 351 | 5.29M | −9.94K (−0.2%) |
| Value | $5.27M | $349 | $5.18M | −$89.1K (−1.7%) |
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Compass Financial Management LLC | 600,230 | $588.2K | 0.07% |
| SNS Financial Group, LLC | 43,000 | $42.1K | 0.00% |
| Harbour Investments, Inc. | 334 | $327 | 0.00% |
| Allied Private Wealth LLC | 240 | $232 | 0.00% |
| Barclays PLC | 203 | $199 | 0.00% |
| Axiom Investment Management LLC | 5 | $5 | 0.00% |
Sold out (12)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Goldman Sachs Group Inc | 70,241 | $69.9K |
| Two Sigma Securities, LLC | 35,887 | $35.7K |
| Nine Masts Capital Ltd | 35,227 | $35.1K |
| Dimensional Fund Advisors LP | 34,923 | $34.8K |
| Jane Street Group, LLC | 34,299 | $34.1K |
| Virtu Financial LLC | 12,324 | $12.0K |
| Callan Family Office, LLC | 11,944 | $11.9K |
| Intrepid Financial Planning Group LLC | 10,500 | $10.5K |
| Level Four Advisory Services, LLC | 10,000 | $9.95K |
| Advisory Services Network, LLC | 1,460 | $1.45K |
| Citigroup Inc | 678 | $675 |
| FMR LLC | 79 | $79 |
Not filed for Q2 2026 yet (1)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| CWM, LLC | 351 | $349 |